The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Open accessAbstract
CONTEXT: There is limited information on the prevalence and correlates of bipolar spectrum disorder in international population-based studies using common methods. OBJECTIVES: To describe the prevalence, impact, patterns of comorbidity, and patterns of service utilization for bipolar spectrum disorder (BPS) in the World Health Organization World Mental Health Survey Initiative. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional, face-to-face, household surveys of 61,392 community adults in 11 countries in the Americas, Europe, and Asia assessed with the World Mental Health version of the World Health Organization Composite International Diagnostic Interview, version 3.0, a fully structured, lay-administered psychiatric diagnostic interview. MAIN OUTCOME MEASURES: Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) disorders, severity, and treatment. RESULTS: The aggregate lifetime prevalences were 0.6% for bipolar type I disorder (BP-I), 0.4% for BP-II, 1.4% for subthreshold BP, and 2.4% for BPS. Twelve-month prevalences were 0.4% for BP-I, 0.3% for BP-II, 0.8% for subthreshold BP, and 1.5% for BPS. Severity of both manic and depressive symptoms as well as suicidal behavior increased monotonically from subthreshold BP to BP-I. By contrast, role impairment was similar across BP subtypes. Symptom severity was greater for depressive episodes than manic episodes, with approximately 74.0% of respondents with depression and 50.9% of respondents with mania reporting severe role impairment. Three-quarters of those with BPS met criteria for at least 1 other disorder, with anxiety disorders (particularly panic attacks) being the most common comorbid condition. Less than half of those with lifetime BPS received mental health treatment, particularly in low-income countries, where only 25.2% reported contact with the mental health system. CONCLUSIONS: Despite cross-site variation in the prevalence rates of BPS, the severity, impact, and patterns of comorbidity were remarkably similar internationally. The uniform increases in clinical correlates, suicidal behavior, and comorbidity across each diagnostic category provide evidence for the validity of the concept of BPS. Treatment needs for BPS are often unmet, particularly in low-income countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the prevalence rates for each subtype varied across the nine countries studied, subthreshold BD was the most common at 1.4% (0.8%), followed by BDI at 0.6% (0.4%) and BDII at 0.4% (0.3%).6”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Worldwide, approximately 43% of patients with BD report suicidal ideation, 21% a plan, and 16% a suicide attempt within the past year.6”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The World Mental Health Survey Initiative reported total lifetime (and 12‐month) prevalence estimates of 2.4% (1.5%) across BDI, BDII and subthreshold BD subtypes.”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Worldwide, approximately 43% of patients with BD report suicidal ideation, 21% a plan, and 16% a suicide attempt within the past year.6”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Worldwide, approximately 43% of patients with BD report suicidal ideation, 21% a plan, and 16% a suicide attempt within the past year.6”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [6]
Experimental — accuracy not yet measured
In the citing paper
“bipolar depression is considerably more persistent than non-bipolar depression,5”
From The Costs of Depression (2012) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
The World Health Report 2002 - Reducing Risks, Promoting Healthy Life
Available, N. A. N. (2003) · Education for Health · doi:10.1080/1357628031000116808 · Cited by 6,078
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Davenport, Y. B., Adland, M. L., Gold, P. W., & Goodwin, F. K. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Self-citationCross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302
Introduction to Variance Estimation.
King, B. F., & Wolter, K. M. (1987) · Journal of the American Statistical Association · doi:10.2307/2289497 · Cited by 1,377
Prevalence and incidence studies of anxiety disorders: A systematic review of the literature
Somers, J. M., Goldner, E. M., Waraich, P., & Hsu, L. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100206 · Cited by 1,114
Assessing Psychiatric Impairment in Primary Care with the Sheehan Disability Scale
Leon, A. C., Olfson, M., Portera, L., Farber, L., & Sheehan, D. V. (1997) · The International Journal of Psychiatry in Medicine · doi:10.2190/t8em-c8yh-373n-1uwd · Cited by 987
Angst, J., Gamma, A., Benazzi, F., Ajdacic‐Gross, V., Eich, D., & Wulf Rössler, A. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00322-1 · Cited by 889
Research works printed but not linked: 4
- [8]Bauer M Pfennig A Epidemiology of bipolar disorders Epilepsia 2005 46 Suppl 4 8 13 15968806
- [12]Pini S de Queiroz V Pagnin D Prevalence and burden of bipolar disorders in European countries Eur Neuropsychopharmacol 2005 8 15 4 425 434 15935623
- [13]Cooper JE Kendell RE Gurland B Sharpe L Copeland JRM Simon R Psychiatric diagnosis in New York and London: A comparative study of mental hospital admissions 1972 London Oxford University Press
- [26]First M Spitzer R Gibbon M Williams J Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP) 2002 New York Biometrics Research, New York State Psychatric Institute
Cited by
Sorted by citations
Items 401–500 of 1,006
Clinical and genetic differences between bipolar disorder type 1 and 2 in multiplex families
Parra, J. G., Streit, F., Forstner, A. J., Strohmaier, J., González, M. J., Flores, S. G., Cabaleiro, F., Noriega, F. D. R., Pérez, F., González, J. H., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01146-0 · Cited by 49
Kolář, D., Kletečková, L., Brožka, H., & Valeš, K. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136003 · Cited by 46
Besag, F., Vasey, M. J., Sharma, A., & Lam, I. C. H. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211045870 · Cited by 52
Advances in Therapeutic Monitoring of Lithium in the Management of Bipolar Disorder
Sheikh, M., Qassem, M., Triantis, I. F., & Kyriacou, P. A. (2022) · Sensors · doi:10.3390/s22030736 · Cited by 44
Structural and functional MRI correlates of inflammation in bipolar disorder: A systematic review
Saccaro, L. F., Crokaert, J., Perroud, N. A., & Piguet, C. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.162 · Cited by 44
Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
Dean, R. L., Marquardt, T., Hurducas, C., Spyridi, S., Barnes, A., Smith, R. P., Cowen, P. J., McShane, R. H., Hawton, K. E., Malhi, G. S., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011611.pub3 · Cited by 43
Biomarkers and staging of bipolar disorder: a systematic review
Roda, Â., Chendo, I., & Kunz, M. (2014) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2014-0002 · Cited by 43
An association between affective lability and executive functioning in bipolar disorder
Aminoff, S. R., Jensen, J., Lagerberg, T. V., Hellvin, T., Sundet, K. S., Andreassen, O. A., & Melle, I. S. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.12.044 · Cited by 45
Gao, K., Wang, Z., Chen, J., Kemp, D. E., Chan, P. K., Conroy, C. M., Serrano, M. B., Ganocy, S. J., & Calabrese, J. R. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.12.004 · Cited by 45
Recent Advances in Sleep-Wake Cycle and Biological Rhythms in Bipolar Disorder
Robillard, R., Naismith, S. L., & Hickie, I. B. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0402-3 · Cited by 43
Trevizol, F., Roversi, K., Dias, V. T., Roversi, K., Pase, C. S., Barcelos, R. C. S., Benvegnú, D. M., Kuhn, F. T., Dolci, G. S., Ross, D. H., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.06.007 · Cited by 42
Leonpacher, A. K., Liebers, D. T., Pirooznia, M., Jancic, D., MacKinnon, D. F., Mondimore, F. M., Schweizer, B. W., Potash, J. B., Zandi, P. P., & Goes, F. S. (2015) · Psychological Medicine · doi:10.1017/s0033291715000446 · Cited by 43
Telomere length in bipolar disorder and lithium response
Squassina, A., Pisanu, C., Corbett, N., & Alda, M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.10.008 · Cited by 48
Furlotti, G., Alisi, M. A., Cazzolla, N., Dragone, P., Durando, L., Magarò, G., Mancini, F., Mangano, G., Ombrato, R., Vitiello, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01208 · Cited by 43
(2012) · PubMed · Cited by 43
Millner, A. J., Ursano, R. J., Hwang, I. H., King, A. J., Naifeh, J. A., Sampson, N. A., Zaslavsky, A. M., Stein, M. B., Kessler, R. C., Nock, M. K., et al. (2017) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12394 · Cited by 42
Self-citationA Review of Asenapine in the Treatment of Bipolar Disorder
Vieta, E., & Montes, J. M. G. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0592-2 · Cited by 44
Roux, P., Raust, A., Cannavo, A.-S., Aubin, V., Aouizerate, B., Azorin, J., Bellivier, F., Belzeaux-R, R., Bougerol, T., Cussac, I., et al. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.117.201335 · Cited by 43
Daveney, J., Panagioti, M., Waheed, W., & Esmail, A. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.03.006 · Cited by 43
Damborská, A., Piguet, C., Aubry, J., Dayer, A. G., Michel, C. M., & Berchio, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00826 · Cited by 45
Andlauer, T. F. M., Parra, J. G., Streit, F., Strohmaier, J., González, M. J., Flores, S. G., Cabaleiro, F., Noriega, F. D. R., Pérez, F., González, J. H., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0558-2 · Cited by 46
Lee, R. S., Pirooznia, M., Guintivano, J., Ly, M. T., Ewald, E. R., Tamashiro, K. L., Gould, T. D., Moran, T. H., & Potash, J. B. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.90 · Cited by 44
Efficacy of antimanic treatments in mixed states
McIntyre, R. S., & Yoon, J. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.00990.x · Cited by 42
Ayuso‐Mateos, J. L., Ávila, C. C., Anaya, C., Cieza, A., Vieta, E., & and the Bipolar Disorders Core Sets Expert Group (2013) · Disability and Rehabilitation · doi:10.3109/09638288.2013.771708 · Cited by 42
Parker, G. B., McCraw, S., Hadži-Pavlović, D., & Fletcher, K. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.002 · Cited by 42
Mismatch negativity in bipolar disorder: A neurophysiological biomarker of intermediate effect?
Hermens, D. F., Chitty, K. M., & Kaur, M. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.026 · Cited by 46
Analysis on speech signal features of manic patients
Zhang, J., Pan, Z., Gui, C., Xue, T., Lin, Y., Zhu, J., & Cui, D. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.12.012 · Cited by 42
Porter, S. V., Lexén, A., Johanson, S., & Bejerholm, U. (2018) · Work · doi:10.3233/wor-182737 · Cited by 42
Abé, C., Rolstad, S., Petrović, P., Ekman, C. J., Sparding, T., Ingvar, M., & Landén, M. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12922 · Cited by 42
Ng, V. W. S., Man, K. K. C., Gao, L., Chan, E. W., Lee, E. H. M., Hayes, J., & Wong, I. C. K. (2021) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5318 · Cited by 42
Bartoli, F., Callovini, T., Cavaleri, D., Cioni, R. M., Bachi, B., Calabrese, A., Moretti, F., Canestro, A., Morreale, M., Nasti, C., et al. (2022) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674221106669 · Cited by 44
de la Serna, E., Vila, M., Sánchez‐Gistau, V., Moreno, D. M., Romero, S., Sugranyes, G., Baeza, I., Llorente, C., Rodríguez-Toscano, E., Sánchez‐Gutiérrez, T., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.014 · Cited by 47
Juul, S., Poulsen, S., Lunn, S., Sørensen, P. S., Jakobsen, J. C., & Simonsen, S. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1099-0 · Cited by 45
Dhillon, S. (2011) · Drugs · doi:10.2165/11208320-000000000-00000 · Cited by 41
Cost-of-Illness Studies for Bipolar Disorder: Systematic Review of International Studies
Jin, H., & McCrone, P. (2015) · PharmacoEconomics · doi:10.1007/s40273-014-0250-y · Cited by 41
Torres, I., Gómez-Barros, N., Colom, F., Jiménez, E., Bosch, R., Bonnín, C. D. M., Martínez‐Arán, A., Casas, M., Vieta, E., Ramos‐Quiroga, J. A., et al. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12426 · Cited by 46
Fountoulakis, K. Ν., Young, A. H., Yatham, L. N., Grunze, H., Vieta, E., Blier, P., Moeller, H. J., & Kasper, S. F. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw091 · Cited by 42
Clinical and Environmental Risk Factors for Bipolar Disorder: Review of Prospective Studies
Marangoni, C., Faedda, G. L., & Baldessarini, R. J. (2018) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000161 · Cited by 40
Post, R. M., Chang, K., & Frye, M. A. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12com08136 · Cited by 41
Modeling bipolar disorder suicidality
Malhi, G. S., Bargh, D. M., Kuiper, S., Coulston, C. M., & Das, P. (2013) · Bipolar Disorders · doi:10.1111/bdi.12093 · Cited by 42
Clinical features, comorbidity, and cognitive impairment in elderly bipolar patients
Rise, I. V., Haro, J. M., & Gjervan, B. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s100843 · Cited by 40
Network analysis of mood symptoms in adolescents with or at high risk for bipolar disorder
Weintraub, M. J., Schneck, C. D., & Miklowitz, D. J. (2019) · Bipolar Disorders · doi:10.1111/bdi.12870 · Cited by 42
Ferentinos, P. P., Preti, A., Veroniki, A. A., Pitsalidis, K. G., Antonis, T., Antoniou, A., & Fountoulakis, K. Ν. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.136 · Cited by 41
The existential crisis of bipolar II disorder
Gitlin, M. J., & Malhi, G. S. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0175-7 · Cited by 42
Rodríguez, V., Alameda, L., Trotta, G., Spinazzola, E., Marino, P., Matheson, S. L., Laurens, K. R., Murray, R. M., & Vassos, E. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa197 · Cited by 40
Biomarkers of neuroprogression and late staging in bipolar disorder: A systematic review
Grewal, S. K., McKinlay, S., Kapczinski, F. P., Pfaffenseller, B., & Wollenhaupt-Aguiar, B. (2022) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674221091731 · Cited by 45
Comparelli, A., Polidori, L., Sarli, G., Pistollato, A., & Pompili, M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.949375 · Cited by 38
Esposti, L. D., Sangiorgi, D., Mencacci, C., Spina, E., Pasina, C., Alacqua, M., & Tour, F. L. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0282-z · Cited by 38
Psychosis and the Control of Lucid Dreaming
Mota, N. B., Resende, A., Mota-Rolim, S. A., Copelli, M., & Ribeiro, S. T. G. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.00294 · Cited by 45
Ou, X., Crane, D., MacIntosh, B. J., Young, L. T., Arnold, P. D., Ameis, S. H., & Goldstein, B. I. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.022 · Cited by 40
Milienne-Petiot, M., Kesby, J. P., Graves, M., van Enkhuizen, J., Semenova, S., Minassian, A., Markou, A., Geyer, M. A., & Young, J. W. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.030 · Cited by 39
Interventions for the management of obesity in people with bipolar disorder
Tully, A., Smyth, S., Conway, Y., Geddes, J. R., Devane, D., Kelly, J. P., & Jordan, F. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013006.pub2 · Cited by 40
Double-blind, placebo-controlled trial of pioglitazone for bipolar depression.
Aftab, A., Kemp, D. E., Ganocy, S., Schinagle, M., Conroy, C. M., Brownrigg, B., D'Arcangelo, N., Goto, T., Woods, N., Serrano, M. B., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.090 · Cited by 41
Ganesh, S., Pallikonda, H. A., Nadella, R. K., More, R. P., Seshadri, M., Viswanath, B., Rao, M. S., Jain, S., & Mukherjee, O. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12788 · Cited by 38
Lamotrigine in the maintenance treatment of bipolar disorder
Hashimoto, Y., Kotake, K., Watanabe, N., Fujiwara, T., & Sakamoto, S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013575.pub2 · Cited by 44
Central levels of tryptophan metabolites in subjects with bipolar disorder
Trepci, A., Sellgren, C. M., Pålsson, E., Brundin, L., Khanlarkhani, N., Schwieler, L., Landén, M., & Erhardt, S. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.018 · Cited by 36
Subramaniam, M., Abdin, E., Vaingankar, J. A., & Chong, S. A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.09.002 · Cited by 40
Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis
Szmulewicz, A. G., Angriman, F., Samamé, C., Ferraris, A., Vigo, D., & Strejilevich, S. A. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12712 · Cited by 37
Bae, M., Lee, K., Baek, J. H., Kim, J. S., Cho, Y., Ryu, S., Ha, K., & Hong, K. S. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.02.012 · Cited by 38
Is coping well a matter of personality? A study of euthymic unipolar and bipolar patients
Coulston, C. M., Bargh, D. M., Tanious, M., Cashman, E. L., Tufrey, K., Curran, G., Kuiper, S., Morgan, H., Lampe, L. A., & Malhi, G. S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.07.012 · Cited by 38
Gaspar, L., van de Werken, M., Johansson, A.-S., Moriggi, E., Owe‐Larsson, B., Kocks, J. W. H., Lundkvist, G. B. S., Gordijn, M. C. M., & Brown, S. A. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12602 · Cited by 39
Jeon, W. J., Dean, B., Scarr, E., & Gibbons, A. S. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150612230045 · Cited by 38
Naifeh, J. A., Ursano, R. J., Kessler, R. C., Zaslavsky, A. M., Nock, M. K., Dempsey, C. L., Bartolanzo, D., Ng, T. H. H., Aliaga, P. A., Zuromski, K. L., et al. (2018) · Depression and Anxiety · doi:10.1002/da.22870 · Cited by 39
Self-citationComorbid Premenstrual Dysphoric Disorder and Bipolar Disorder: A Review
Slyepchenko, A., Minuzzi, L., & Frey, B. N. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.719241 · Cited by 38
Psychological resilience and mood disorders: a systematic review and meta-analysis
Imran, A., Tariq, S., Kapczinski, F. P., & Cardoso, T. D. A. (2022) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2022-0524 · Cited by 52
Perra, A., Galetti, A., Zaccheddu, R., Locci, A., Piludu, F., Preti, A., Primavera, D., Natale, L. D., Nardi, A. E., Kurotschka, P. K., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062142 · Cited by 39
The economic and humanistic burden of bipolar disorder in adults in the United States
Dembek, C., Mackie, D. S., Modi, K., Zhu, Y., Niu, X., & Grinnell, T. (2023) · Annals of General Psychiatry · doi:10.1186/s12991-023-00440-7 · Cited by 43
Miller, L. J., Ghadiali, N. Y., LaRusso, E. M., Wahlen, K. J., Avni-Barron, O., Mittal, L. P., & Greene, J. A. (2014) · Health Care For Women International · doi:10.1080/07399332.2014.962138 · Cited by 39
Haenisch, F., Alsaif, M., Guest, P. C., Rahmoune, H., Dickerson, F., Yolken, R. H., & Bahn, S. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.12.008 · Cited by 37
Novel urinary biomarkers for diagnosing bipolar disorder
Zheng, P., Wei, Y.-D., Yao, G.-E., Ren, G., Guo, J., Zhou, C., Zhong, J., Cao, D., Zhou, L.-K., & Xie, P. (2013) · Metabolomics · doi:10.1007/s11306-013-0508-y · Cited by 37
Ahmad, A., Sheikh, S., Shah, T. S., Reddy, M., Prasad, B., Verma, K., Chandrakant, B., Paithankar, M., Kale, P., Solanki, R., et al. (2016) · Clinical and Translational Science · doi:10.1111/cts.12407 · Cited by 37
Association between gastrointestinal symptoms and affectivity in patients with bipolar disorder
Karling, P., Maripuu, M., Wikgren, M., Adolfsson, R., & Norrback, K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i38.8540 · Cited by 37
Enrichment of deleterious variants of mitochondrial DNA polymerase gene (POLG1) in bipolar disorder
Kasahara, T., Ishiwata, M., Kakiuchi, C., Fuke, S., Iwata, N., Ozaki, N., Kunugi, H., Minabe, Y., Nakamura, K., Iwata, Y., et al. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12496 · Cited by 37
Abnormal sleep duration associated with hastened depressive recurrence in bipolar disorder
Gershon, A., Do, D., Satyanarayana, S., Shah, S., Yuen, L. D., Hooshmand, F., Miller, S., Wang, P. W., & Ketter, T. A. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.05.015 · Cited by 38
Bipolar spectrum in major depressive disorders
Angst, J., Merikangas, K. R., Cui, L., Meter, A. V., Ajdacic‐Gross, V., & Wulf Rössler, A. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0927-x · Cited by 38
Self-citationAssessment of Complement Cascade Components in Patients With Bipolar Disorder
Reginia, A., Kucharska–Mazur, J., Jabłoński, M., Budkowska, M., Dołęgowska, B., Sagan, L. M., Misiak, B., Ratajczak, M. Z., RYBAKOWSKI, J. K., & Samochowiec, J. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00614 · Cited by 37
Whole-exome sequencing of 81 individuals from 27 multiply affected bipolar disorder families
Forstner, A. J., Fischer, S. B., Schenk, L. M., Strohmaier, J., Maaser‐Hecker, A., Reinbold, C. S., Sivalingam, S., Hecker, J., Streit, F., Degenhardt, F., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0732-y · Cited by 36
Stout, J. A., Hozer, F., Coste, A., Mauconduit, F., Djebrani-Oussedik, N., Sarrazin, S., Poupon, J., Meyrel, M., Romanzetti, S., Étain, B., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.1181 · Cited by 27
Zhang, L., Li, W., Wang, L., Bai, T., Ji, G., Wang, K., & Tian, Y. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.122 · Cited by 36
Tee, M. M. K., & Au, C. W. (2020) · Psychiatric Quarterly · doi:10.1007/s11126-020-09822-6 · Cited by 37
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
Jung, Y. J., Tweedie, D., Scerba, M. T., Kim, D. S., Palmas, M. F., Pisanu, A., Carta, A. R., & Greig, N. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.656921 · Cited by 37
Systematic analysis of exonic germline and postzygotic de novo mutations in bipolar disorder
Nishioka, M., Kazuno, A., Nakamura, T., Sakai, N., Hayama, T., Fujii, K., Matsuo, K., Komori, A., Ishiwata, M., Watanabe, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23453-w · Cited by 38
Genetic overlap and causal associations between smoking behaviours and mental health
Barkhuizen, W., Dudbridge, F., & Ronald, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-93962-7 · Cited by 40
Angrand, L., Boukouaci, W., Lajnef, M., Richard, J., Andreazza, A. C., Wu, C.-L., Bouassida, J., Rafik, I., Foiselle, M., Mezouad, E., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.09.003 · Cited by 40
Francesca, M. M., Efisia, L. M., Alessandra, G. M., Alacqua, M., & Giovanni, C. M. (2014) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/1745017901410010042 · Cited by 36
Using apps for bipolar disorder – An online survey of healthcare provider perspectives and practices
Morton, E., Torous, J., Murray, G., & Michalak, E. E. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.047 · Cited by 36
Wong, S. M. Y., Chen, E. Y. H., Suen, Y. N., Wong, C. S. M., Chang, W. C., Chan, S. K. W., McGorry, P. D., Morgan, C., van Os, J., McDaid, D., et al. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100881 · Cited by 40
Hsu, C., Chou, P., Brunoni, A. R., Hung, K., Tseng, P., Liang, C., Carvalho, A. F., Vieta, E., Tu, Y., Lin, P., et al. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105483 · Cited by 38
Andreazza, A. C. (2012) · Molecular BioSystems · doi:10.1039/c2mb25118c · Cited by 36
Mesman, E., Birmaher, B. B., Goldstein, B. I., Goldstein, T. R., Derks, E. M., Vleeschouwer, M., Hickey, M. B., Axelson, D., Monk, K., Diler, R. S., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.011 · Cited by 36
Brain Structure and Function in Women with Comorbid Bipolar and Premenstrual Dysphoric Disorder
Syan, S. K., Minuzzi, L., Smith, M., Costescu, D., Allega, O. R., Hall, G. B., & Frey, B. N. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00301 · Cited by 35
An update on adjunctive treatment options for bipolar disorder
Dean, O. M., Gliddon, E., Rheenen, T. E. V., Giorlando, F., Davidson, S. K., Kaur, M., Ngô, T. T., & Williams, L. J. (2018) · Bipolar Disorders · doi:10.1111/bdi.12601 · Cited by 36
The utility of pharmacogenetic testing to support the treatment of bipolar disorder
Ielmini, M., Poloni, N., Caselli, I., Espadaler, J., Tuson, M., Grecchi, A., & Callegari, C. (2018) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s160967 · Cited by 36
Bipolar Disorder Among Patients Diagnosed With Frontotemporal Dementia
Mendez, M. F., Parand, L., & Akhlaghipour, G. (2020) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20010003 · Cited by 36
Lai, J., Jiang, J., Zhang, P., Xi, C., Wu, L., Gao, X., Zhang, D., Du, Y., Li, Q., Diao, X., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.146 · Cited by 36
Cytomegalovirus Antibody Elevation in Bipolar Disorder: Relation to Elevated Mood States
Prossin, A. R., Yolken, R. H., Kamali, M., Heitzeg, M. M., Kaplow, J. B., Coryell, W. H., & McInnis, M. G. (2015) · Neural Plasticity · doi:10.1155/2015/939780 · Cited by 36
Bipolar disorder in Asia: Illness course and contributing factors
Subramanian, K., Sarkar, S., & Kattimani, S. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.04.009 · Cited by 36
Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies
Young, A. H., Calabrese, J. R., Gustafsson, U., Berk, M., McElroy, S. L., Thase, M. E., Suppes, T., & Earley, W. (2013) · International Journal of Bipolar Disorders · doi:10.1186/2194-7511-1-10 · Cited by 35
Course of residual symptoms according to the duration of euthymia in remitted bipolar patients
Samalin, L., Reinares, M., de Chazeron, I., Torrent, C., Bonnín, C. D. M., Hidalgo‐Mazzei, D., Murru, A., Pacchiarotti, I., Geoffroy, P. A., Bellivier, F., et al. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12568 · Cited by 34
Empowering School Staff to Implement Effective School Mental Health Services
Kern, L., Weist, M. D., Mathur, S. R., & Barber, B. R. (2021) · Behavioral Disorders · doi:10.1177/01987429211030860 · Cited by 35
Metadata
- Authors
- Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., Ladea, M., Medina-Mora, M. E., Ono, Y., Posada-Villa, J., Sagar, R., Wells, J. E., & Zarkov, Z.
- Affiliations
- National Institute of Mental Health (US)
- Harvard University (US)
- Chinese University of Hong Kong (HK)
- Universidade de São Paulo (BR)
- Shenzhen KangNing Hospital (CN)
- University of Balamand (LB)
- Carol Davila University of Medicine and Pharmacy (RO)
- Keio University (JP)
- All India Institute of Medical Sciences (IN)
- ORCID
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2011-03-07
- Volume
- 68
- Issue
- 3
- Pages
- 241
- ISSN
- 0003-990X (ISSN-L)
- PMC
- PMC3486639
- OpenAlex
- W1984344128
- Cited by
- 2,627
- References
- 41
- Citations by year
- 2026: 135 · 2025: 212 · 2024: 191 · 2023: 190 · 2022: 232 · 2021: 231 · 2020: 210 · 2019: 219 · 2018: 173 · 2017: 179 · 2016: 162 · 2015: 142 · 2014: 126 · 2013: 111 · 2012: 80
- FWCI
- 76.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r13mh066849-04, 5r01mh069864-04, 5r01mh070884-05)
- National Institute of Mental Health (R13-MH-066849, R01‐MH070884, U01-MH-60220, U01MH060220, R01‐MH069864)
- National Institute on Drug Abuse (K05DA015799, R01DA016558)
- Fogarty International Center (R03TW006481)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- bipolar spectrum disorders, bipolar I disorder, bipolar II disorder, prevalence, comorbidities, anxiety disorders, panic attacks, suicidal behavior, symptom severity, role impairment, mental health service utilization, treatment needs, low-income countries, cross-national comparison
- MeSH terms
- Adolescent, Adult, Bipolar Disorder, Cross-Sectional Studies, Cross-Cultural Comparison, Depressive Disorder, Major, Major Depressive Disorder, Female, Health Surveys, Humans, Male, Mental Health Services, Middle Aged, Sex Factors, Socioeconomic Factors, Suicide, Attempted, Utilization Review, World Health Organization, Comorbidity, Age of Onset, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
